Evolus Announces Successful Completion of the Jeuveau® Experience Treatment (J.E.T) Program
September 04, 2019 06:00 ET
|
Evolus
Jeuveau® Achieves Number Three Unit Share Position1 in the U.S. Within 90 Days of Launch NEWPORT BEACH, Calif., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty...
Evolus to Participate in Two Upcoming Investor Conferences
August 22, 2019 16:05 ET
|
Evolus
NEWPORT BEACH, Calif., Aug. 22, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today...
Evolus Reports Second Quarter 2019 Financial Results
August 12, 2019 07:01 ET
|
Evolus
Launched Jeuveau® in the United States on May 15 Jeuveau® Experience Treatment (J.E.T.) Program Exceeds Expectations Generated $2.3 Million in Jeuveau® Net Revenue in Q2 2019 NEWPORT BEACH,...
Evolus to Report Second Quarter 2019 Financial Results and Provide a Business Update on Monday, August 12, 2019
August 01, 2019 08:30 ET
|
Evolus
NEWPORT BEACH, Calif., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products,...
Evolus Expands Board of Directors with Appointment of Independent Directors Peter Farrell, Ph.D. and Karah Parschauer, J.D.
July 15, 2019 08:30 ET
|
Evolus
NEWPORT BEACH, Calif., July 15, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today...
Evolus Provides Update on Nuceiva™ Marketing Authorization Application in Europe
June 10, 2019 09:00 ET
|
Evolus
NEWPORT BEACH, Calif., June 10, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS) today provided an update on the marketing authorization application (MAA) for Nuceiva™ in Europe that may result...
Evolus Accelerates Next Phase of U.S. Launch of Jeuveau™ with ‘#NEWTOX NOW’ Consumer Conversion Program
June 05, 2019 07:45 ET
|
Evolus
NEWPORT BEACH, Calif., June 05, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS) today announced the launch of the ‘#NEWTOX NOW’ consumer conversion program following the rapid adoption of the...
Evolus to Participate in Three Upcoming Investor Conferences
May 28, 2019 16:01 ET
|
Evolus
NEWPORT BEACH, Calif., May 28, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today...
Evolus Announces First Shipment of Jeuveau™ (prabotulinumtoxinA-xvfs) to Customers in the United States
May 15, 2019 09:00 ET
|
Evolus
NEWPORT BEACH, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today...
Evolus Reports First Quarter 2019 Financial Results
April 30, 2019 16:01 ET
|
Evolus
NEWPORT BEACH, Calif., April 30, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products,...